WIRobotics raises $63M Series B

WIRobotics said on May 14 that it had completed a 95 billion won Series B round, which the company described as approximately $68 million, to accelerate development of its ALLEX humanoid robot platform and build mass-production systems. The South Korean robotics company said the round came about two years after its March 2024 Series A financing of 13 billion won. (prnewswire.com) WIRobotics said JB Investment led the financing, with InterVest, Hana Ventures, Smilegate Investment, SBVA, NH Investment & Securities, Company K Partners, GU Investment and FuturePlay also participating. Korea Biomedical Review reported on May 15 that WIRobotics planned to begin selling ALLEX to AI companies, global technology firms and major research institutions in the fourth quarter of 2026. (koreabiomed.com) The company told the publication that the funding would go mainly toward ALLEX development and mass-production systems. “The highest priority is ALLEX development and building a mass-production system,” the company said, according to the report. ### How large was the round, and why do some reports show different dollar figures? WIRobotics said the round totaled 95 billion won and described that as approximately $68 million in its May 14 announcement. Korea Biomedical Review, citing the same 95 billion won figure a day later, translated the amount as about $63 million. (prnewswire.com) The won amount is consistent across both reports, while the dollar figure varies with exchange-rate conversion and rounding. March 2024 is the company’s last disclosed prior financing date in the announcement, when WIRobotics said it raised 13 billion won in Series A funding. The gap between rounds gives WIRobotics a larger balance sheet as it shifts from wearable robots toward a broader humanoid platform strategy. (koreabiomed.com) ### Who backed the financing, and what does that say about the company’s plan? JB Investment led the Series B, according to WIRobotics, and the syndicate included InterVest, Hana Ventures, Smilegate Investment, SBVA, NH Investment & Securities, Company K Partners, GU Investment and FuturePlay. WIRobotics said the financing reflected confidence in its “next-generation robotics technologies and commercialization potential,” though that characterization came from the company. (prnewswire.com) AWS, NVIDIA and MassRobotics were not investors in the round, but WIRobotics said in March that it had been selected for the 2026 Physical AI Fellowship powered by those groups. The company said the program would support development of humanoid systems for industrial, logistics and service applications through cloud credits, technical guidance and access to NVIDIA’s robotics tools. (prnewswire.com) ### What exactly is ALLEX, and how does it connect to WIRobotics’ existing business? WIRobotics describes ALLEX as a humanoid robotics platform built on technologies designed to understand and augment human movement. The company said it is using know-how and data gathered from WIM, its commercial walking-assist wearable robot, as part of that effort. (prnewswire.com) WIM has surpassed 3,000 cumulative units sold and expanded into Europe, China, Türkiye and Japan, WIRobotics said. Korea Biomedical Review reported that the company argues those deployments gave it years of real-world movement and interaction data that can be used in humanoid development. (wirobotics.com) ### When will customers be able to buy ALLEX? The fourth quarter of 2026 is WIRobotics’ target for beginning ALLEX sales to AI companies and research institutions, according to Korea Biomedical Review. In its own announcement, the company said it planned to launch a research-focused humanoid platform later this year and pursue initial commercialization while preparing for mass production by late next year. (prnewswire.com) A planned California subsidiary will handle overseas partnerships and distribution agreements for WIM and ALLEX, Korea Biomedical Review reported. The company also said it was in discussions with a global automotive manufacturer on manufacturing-environment platform validation, though deployment timing had not been finalized. (prnewswire.com) ### What production target has WIRobotics put on the table? By the end of 2027, WIRobotics is targeting annual production capacity of more than 300 ALLEX units, Korea Biomedical Review reported. The company said more detailed discussions on factory applications were expected after 2027, when it completes Mobile ALLEX, a wheel-based version of the robot. (koreabiomed.com) AWS, NVIDIA and MassRobotics are scheduled to host showcase events tied to the Physical AI Fellowship, including AWS re:Invent 2026, according to WIRobotics’ March announcement. Before then, WIRobotics has said its next milestones are a research-focused humanoid launch in late 2026 and mass-production readiness the following year. (wirobotics.com) (koreabiomed.com)